BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yu J, Lv YM, Yang P, Jiang YZ, Qin XR, Wang XY. Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection. World J Gastroenterol 2023; 29(20): 3133-3144 [PMID: PMC10280792 DOI: 10.3748/wjg.v29.i20.3133]
URL: https://www.wjgnet.com/1007-9327/full/v29/i20/3133.htm
Number Citing Articles
1
Valerie Josephine Dirjayanto, Jessica Audrey, Daniel Martin Simadibrata. Vonoprazan-amoxicillin dual regimen with <i>Saccharomyces boulardii</i> as a rescue therapy for <i>Helicobacter pylori</i>: Current perspectives and implicationsWorld Journal of Gastroenterology 2024; 30(10): 1280-1286 doi: 10.3748/wjg.v30.i10.1280
2
Jie Zhang, Xin Cao, Kai Ma, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang. Safety and effectiveness of dual therapy for Helicobacter pylori infection and the effect on the glycated hemoglobin level in type 2 diabetesScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-85628-5